Hyperbaric Oxygen Therapy for Optic Neuropathies

Last updated: September 24, 2024
Sponsor: Stanford University
Overall Status: Active - Recruiting

Phase

N/A

Condition

Vision Loss

Glaucoma

Treatment

Hyperbaric Oxygen

Sham Hyperbaric Oxygen

Clinical Study ID

NCT06128720
59547
  • Ages > 18
  • All Genders

Study Summary

The purpose of the study is to evaluate the neuroprotective efficacy of hyperbaric oxygen for the treatment in patients with optic neuropathy.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Patients must meet all of the following criteria to join the study (all eligibilitycriteria must be met at the screening and baseline visits unless otherwise noted):

  • Participant must be at least 18.

  • Participant must has the ability to comply with the requirements of the study andcomplete the schedule of events (SOE).

  • Participant's with clinical evidence of optic neuropathy.

  • Participant must understand and sign the informed consent. If the participant'svision is impaired to the point where he/she cannot read the informed consentdocument, the document will be read to the participant in its entirety.

Exclusion

Exclusion Criteria:

  • Participant is unable to comply with study procedures or follow-up visits.

  • Participant has evidence of corneal opacification or lack of optical clarity.

  • Participant is currently participating in or has within the last 3 monthsparticipated in any other clinical trial of a drug by ocular (if in the study eye)or systemic administration.

  • Participant is pregnant or lactating.

  • Participant has, in the opinion of the investigator, any physical or mentalcondition that would increase the risk of participation in the study or mayinterfere with the study procedures, evaluations and outcome assessments.

  • Children and comatose patients.

  • Participant abusing drugs or alcohol.

  • Prior treatment with hyperbaric oxygen within the last 6 months.

  • Participant with claustrophobia or that cannot decompress properly.

Study Design

Total Participants: 60
Treatment Group(s): 2
Primary Treatment: Hyperbaric Oxygen
Phase:
Study Start date:
November 01, 2022
Estimated Completion Date:
December 31, 2025

Connect with a study center

  • Byers Eye Institute

    Palo Alto, California 94303
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.